Mytos logo

MytosAutomating the most manual process in biotech - growing cells

Mytos builds machines that automate the growing of human cells for biotech and pharma companies. Our machines sit on-prem at customer sites, growing cells which they use for testing during early-stage drug development. Even though testing on cells is so critical for developing new drugs, today they're all grown totally manually, the same as 100 years ago! With our machines, for the first time our customers can hands-off manipulate and monitor batches of cells from the cloud. We've already working with some of the biggest pharma companies. Mytos has the opportunity to change the way the entire industry works - join us and help us get there!

2018-05-03
Active
Early
S18
26
Healthcare
United KingdomEuropeRemotePartly Remote
Mytos screenshot
More About Mytos

Mytos - Infrastructure for Cell Manufacturing

Revolutionizing Cell Culture Automation

Key Features

  • Scalable: Scale cell production without additional hiring.
  • High Quality: Consistent high-quality cells every time.
  • Robust: Eliminate failed cell batches due to contamination or human error.
  • High Productivity: One technician can produce the cell output of ten scientists working manually.

Use Cases

  • Drug Discovery: $5B market with 40,000 machines worth of cell production across drug development.
  • Cell Therapy: $20B market with 2 million patient cell batches a year by 2030.

Pricing

Contact us to learn more about our pricing options tailored to your specific needs.

Teams

Our team comprises top-tier hardware engineers, software engineers, and biologists dedicated to inventing the infrastructure for biotech. Learn how Mytos can automate your cell culture processes.

Book a call or get a brochure to discover more about how Mytos can transform your cell manufacturing operations.